MEDFORD, Mass., July 24, 2018 /PRNewswire/ -- GreenLight Biosciences, Inc., a biotechnology company developing RNA-based
"Mick brings global leadership experience building successful commercial teams in agricultural companies," said Dr. Andrey J. Zarur, President and Chief Executive Officer of GreenLight. "He is joining GreenLight at a critical juncture as we continue to advance our pipeline of RNA-based crop protection products. Mick's expertise and experience in forming partnerships and successfully commercializing crop protection products in agriculture will solidify our strategies to make our highly effective and specific, environmentally friendly crop protection products available to farmers and growers as soon as possible."
"Farmers, growers and the value chain are looking for greener crop protection products. The team at GreenLight has demonstrated a great passion to advance this important new class of crop protection products," said Mr. Messman. "I'm very pleased to join their efforts and lead the commercial strategy for GreenLight's business and product portfolio."
Mick has held increasingly senior marketing and commercial leadership roles in agricultural companies over his career. Most recently, as Director, Seed Applied and Biological Technologies at Corteva, where he led the efforts to create a new portfolio built through internal discovery and collaborations. He also led the US Product Marketing team for Pioneer, and was instrumental in multiple product launches. Prior to Dupont, Mick held global and U.S. commercial roles at Syngenta, where he worked in early stage businesses and market development. Mick's interest in agriculture stems from growing up on a family farm in Nebraska. He earned his M.B.A. at Colorado State University, and a Bachelor of Science in Agribusiness from the University of Nebraska, Lincoln.
GreenLight Biosciences, Inc. is a Medford, MA-based life sciences company committed to ensuring sustainable global development through the development of RNA-based products. GreenLight is currently developing RNA products for agricultural and health applications, and collaborating with industry leaders, to pave the way for advancements in vaccine development, pandemic preparation, crop management, and crop protection.
Contact: Jackie Mason, 617-616-8188, email@example.com
View original content:http://www.prnewswire.com/news-releases/greenlight-biosciences-welcomes-new-chief-commercial-officer-300685570.html
SOURCE GreenLight Biosciences, Inc.
Subscribe to our Free Newsletters!
Osteolysis refers to breaking down of bone tissue. Bone loss occurs due to resorption of bone by ...
Patisiran injection, recently approved by FDA to treat polyneuropathy, a disease that causes ...
Dysgraphia or disorder of written expression is a childhood learning disorder marked by poor ...View All